Tag Archives | Kite Pharma Inc.

Kite Pharma

Kite Pharma: Proxy Score 50

Kite Pharma Inc (NASD:KITE), a clinical-stage biopharmaceutical company, focused on the development and commercialization of novel cancer immunotherapy products and is one of the stocks in my portfolio. Their annual meeting is coming up on 6/8/2015. ProxyDemocracy.org had the vote of one fund when I checked and voted on 6/1/2015.  However, I also picked up the votes of CalSTRS. […]

Continue Reading ·

Powered by WordPress. Designed by WooThemes